"As patients have just started purchasing medical cannabis, the State has not had the opportunity to evaluate the benefits and costs of the pilot program or determine areas for improvement or even whether to extend the program beyond its pilot period," she said in an email. "At this time, it is premature to expand the pilot program before there is the ability to evaluate it under the current statutory requirements."